Abstract
Background:
Exercise has a positive impact on patients with osteosarcoma, improving function, reducing disability, maintaining independence and quality of life. Exercise may also directly affect the effectiveness of cancer treatment. Cell division cycle-associated protein 4 (CDCA4) is reported to function importantly during numerous human cancers development. Nevertheless, the details toward CDCA4 function are still to be investigated.
Methods:
This study comprehensively analyzed the GSE74194 database and obtained aerobic exercise-related genes. Protein-protein interaction network (PPI) and Gene Ontology (GO) analysis were performed on the differentially expressed genes (DEGs). Quantitative reverse transcription polymerase chain reaction (qRT-PCR) and tumor genome atlas (TCGA) data mining were applied to measure aerobic exercise-related gene CDCA4 level in osteosarcoma tissue. We conducted lots of functional experiments to uncover CDCA4 function and its corresponding mechanism in osteosarcoma.
Results:
We screened a total of 547 DEGs related to aerobic exercise, of which 373 were up-regulated and 174 were down-regulated. PPI analysis revealed 90 genes that might play key roles. GO analysis showed that aerobic exercise-related DEGs were significantly enriched during the mitotic cell cycle, cell division, mitotic nuclear division and sister chromatid segregation, nuclear division, microtubule cytoskeleton organization involved protein, microtubule-based process, spindle organization, G2/M transition of mitotic cell cycle. Our results indicated that CDCA4 was increased in osteosarcoma tissues and cell lines, and its level had association with high mortality of osteosarcoma patients. Further studies revealed that absence of CDCA4 largely hindered osteosarcoma cancer cell proliferation, invasion, and migration.
Conclusion:
Comprehensive bioinformatics analysis improves our understanding of the underlying molecular mechanisms of aerobic exercise on osteosarcoma. This provides evidence for the effect of aerobic exercise on CDCA4 expression. Our data suggested that CDCA4 could facilitate osteosarcoma development, and gave a hint that CDCA4 was a candidate target in the treatment of osteosarcoma, aerobic exercise might help the treatment and prognosis of patients with osteosarcoma.
Introduction
Osteosarcoma, whose morbidity ranks high in adolescence, is the most common major bone tumor (; ; ). At 15–19 years old, the annual morbidity is 8–11 per million each year (). At present, the details relating to oncogenesis are not conclusive. The treatment schedules for osteosarcoma involve surgery, chemotherapy and radiotherapy. However, the therapies effect is far from satisfactory and often recurs (). Currently, 60–65% of patients treated with multi-drug neoadjuvant chemotherapy can be cured, but it also causes a number of side effects which adversely affect the patients quality of life (; ). Unfortunately, this cure rate has not improved for many years, and the attempts to improve the prognosis through intensive treatment have been unsuccessful. In addition, the drugs presently included in standard chemotherapy are almost exactly the same as those used since the 1970s–80s (). Thus, new treatments and drugs are needed to improve the overall survival rate of osteosarcoma patients. Through the systematic integration of drug combination screening, bioinformatics analysis, functional research, and correlation with clinical results, found that imatinib could enhance the effect of metformin on Ewing’s sarcoma by weakening the tumor hypoxia response. Also, through deep RNA sequencing, revealed the dynamic regulation of miRNA, lncRNAs, and mRNAs in osteosarcoma tumorigenesis and pulmonary metastasis. Despite all these advances have been made utilizing bioinformatics and science technologies to find candidate targets for osteosarcoma treatment, the outcomes of osteosarcoma patients in clinical are not significantly ameliorated (; ; ). Herein, there is an urgent need to discover available targets and explore effective treatment for osteosarcoma.
The main goal of the new field of sports oncology research is to identify the efficacy and biological mechanisms by which aerobic exercise affects the development and metastasis of cancer (). Studies have found that a combination of aerobic exercise and breathing muscle training can be included in the rehabilitation plan of non-small cell lung cancer (NSCLC) patients with poor conditions after lung resection (). It is found in breast cancer that both aerobic exercise and resistance exercise cannot prominently improve the cancer-specific quality of life of breast cancer patients undergoing chemotherapy, whereas, it can improve the constitution, body composition and chemotherapy completion rate, without causing lymphedema or major disease events (; ; ). The feasibility and use of exercise or physical exercise in the treatment of osteosarcoma and its survivors have also been discussed (). However, little is known about the effect of aerobic exercise on osteosarcoma and its regulation of osteosarcoma gene expression profile.
Cell division cycle-associated protein 4 (CDCA4), also called SEI-3/hematopoietic progenitor protein, has been reported to have a unique role in regulating the cell cycle (; ). Presently, there are increasing researches about the impacts of CDCA4 on human diseases. For instance, Pang S et al. revealed that CDCA4 probably participated in the modulation of human triple negative breast cancer (TNBC) progression and CDCA4 might be a newly produced target in TNBC treatment field (). Though Alderman C, et al. reported that microRNA-15a targeted CDCA4 directly and impeded malignant melanoma growth and invasiveness, the veil of CDCA4 was not fully uncovered ().
Here, we selected the GSE74194 dataset from the Gene Expression Omnibus (GEO) database to identify genes related to aerobic exercise. We have obtained differentially expressed genes (DEGs) between anaerobic exercise and aerobic exercise. A protein-protein interaction network (PPI) was constructed to identify key genes related to aerobic exercise. The function of the selected DEGs was further summarized by Gene Ontology (GO) annotation analysis. Kaplan-Meier plotter analyzed the survival of the CDCA4 gene. Based on The Cancer Genome Atlas (TCGA) database, the gene expression level and clinicopathological characteristics of CDCA4 were analyzed. Our data indicated that osteosarcoma tissues and cell lines highly expressed CDCA4. Functional assays demonstrated that osteosarcoma cancer cell proliferation, invasion, and migration could be dramatically inhibited upon knockdown CDCA4. Our data collectively suggested that aerobic exercise-related CDCA4 displayed as a potential carcinogene in osteosarcoma development, implying that it was a prospective marker for osteosarcoma prognosis.
Materials and Methods
Public Data
GSE741941 was downloaded from the GEO database. The database contained transcriptome profiles of aerobic and anaerobic exercises of 10 male subjects. The Cancer Genome Atlas (TCGA)2 with more than 20,000 molecular characteristics of primary cancers and matched normal ones covering 33 cancer types sample, is a landmark cancer genome project. The joint efforts of the National Cancer Institute and the National Human Genome Institute initially led in 2006, bringing together researchers from different disciplines and multiple institutions.
Analysis of GO Term Enrichment and Protein-Protein Interaction Network
The protein-protein interaction (PPI) network was applied to identify primary genes and gene modules participating in aerobic exercise. The detailed differential expressed genes (DEGs) information of PPI network derived from The Search Tool for the Retrieval of Interacting Genes (STRING) database3 and PPI network was established by Cytoscape software. Considering the bioconductor package “GOstats,” the significance of DEGs was assessed from biological process via the GO item enrichment analysis. P < 0.05 indicated statistically significant, representing significant enrichment.
Cell Culture
Human osteosarcoma cell lines (SW1353, U2OS, HOS) and normal osteoblasts (hFOB1.19) were extracted from the cell bank of the Chinese Academy of Sciences (Shanghai). RPMI 1640 (Gibco, Gaithersburg, MD., United States) was cultured with 10% fetal bovine serum (HyClone, Logan, United States) and 1% penicillin/streptomycin (Gibco) in an incubator at 37°C and 5% CO2. All cells were identified by short tandem repeat (STR) and passaged less than 6 months after recovery.
Preparation of Tissues
Twelve-pair glioma tissue and matched normal tissue were isolated from patients with glioma surgically removed at Minhang Hospital (Shanghai, China). No preoperative chemotherapy or radiotherapy were subjected to patients in this research. All studies were approved by The ethics committee of Minhang Hospital and observed with the Declaration of Helsinki. All the subjects received written informed consent.
Transfection of Cells
The cells were seeded into 6-well plates 1 day prior to transfection. The second day, when cell confluency was around 70–80%, Lipofectamine 2000 and small interfering RNA were diluted in serum-free medium for 5 min. Then diluted reagents were gently mixed and maintained for another 20 min. Next, cells were mixed with the mixture and incubated for 4–6 h. After that, cells were harvested for further experiments. The sequences of siRNAs were as follows: si-CDCA4, GCAGCUUUGCCACAUGCUUTT; si-NC, UUCUCCGAACGUGUCACGUTT.
Extraction and Quantation of RNA
Whole RNA was obtained from cultured cells and fresh tissue using Trizol Regent (Invitrogen, United States). cDNA was synthesized using PrimeScript RT Kit (Promega, Madison, Wisconsin, United States), and qRT-PCR was performed using SYBR premixed Ex-TAQTM(Dalian, China) on ABI 7500 real-time PCR system (Foster City applied Biological Systems, United States). GAPDH was an internal control. Determination of relative gene expression 2–ΔΔCt method.
Cell Proliferation Assay
1 × 103 cells were cultured overnight in 96-well plates. CCK-8 (Dojindo, Rockville, United States) was added to the above cells and incubated for 2 h. OD value of 450 nm was measured on an automatic label reader (Bio-RAD, Hercules, United States). Our data was derived from three independent experiments in triplicate.
Transwell Migration Assay
2 × 105 cells were suspended in serum-free medium and then placed in the superior compartment of 8 μm-well Transwells (BD Biosciences, San José, CA, United States). The lower compartment with 10% FBS was regarded as a chemical attractant. After cells incubating at 37°C for 2 days and staining for 15 min, 5 fields of view (× 200) were stochastically chosen under the microscope to calculate translocated cells.
Statistical Analysis
SPSS19.0 statistical software package was executed to analyze statistics. The mean ± standard deviation represented the data, derived from three separate experiments. Student’s t-test and one-way variance were applied to analyze qRT-PCR data. Two-tailed paired Student’s t-test was used for comparison between groups. Survival curves of patients with different CDCA4 expression levels were plotted and compared using Kaplan-Meier method. P < 0.05 suggested significant difference.
Results
Identification of Genes Related to Aerobic Exercise
Twenty subsets of transcriptome data were downloaded from the database GSE74194, including GSM1914302, GSM1914318, GSM1914300, GSM1914314, GSM1914304, GSM1914306, GSM1914310, GSM1914316, GSM1914308, GSM1914312, GSM1914301, GSM1914319, GSM1914317, GSM1914303, GSM1914313, GSM1914313, GSM1914305, and GSM1914315. The mRNA expression levels of the anaerobic and aerobic exercise groups were analyzed using the database. Heatmap analysis showed that there were 547 DEGs between the anaerobic exercise group and the aerobic exercise group, with 373 up-regulated genes and 174 down-regulated genes (Figure 1). Among them, CDCA4 was down-regulated.
FIGURE 1
Analysis of PPI Network and Biological Processes
On basis of the STRING database, Cytoscape software was performed to establish the DEGs PPI network. Ninety nodes were included in this network and probably displayed crucially in aerobic exercise (Figure 2). GO enrichment analysis of DEGs revealed that 20 terms were significantly enriched in biological processes, comprising mitotic cell cycle, cell division, mitotic nuclear division and sister chromatid segregation, nuclear division, microtubule cytoskeleton organization involved protein, microtubule-based process, spindle organization and G2/M transition of mitotic cell cycle (Figure 3).
FIGURE 2
FIGURE 3
Highly Expressed CDCA4 in Osteosarcoma Patients Gave Rise to Poor Prognosis
Kaplan-Meier survival analysis revealed that highly expressed CDCA4 in osteosarcoma patients led to shorter overall survival (OS) and disease free survival time (Figures 4A,B). In addition, patients with highly expressed CDCA4 displayed shorter metastasis-free survival (MFS), compared to those with lowly expressed CDCA4 (Figure 4C).
FIGURE 4
In order to explore whether CDCA4 expression was related to the clinicopathological features of osteosarcoma, we further analyzed the clinical data of osteosarcoma patients. Figure 5A showed that compared with normal tissues, CDCA4 expression in Sarcoma (SARC) tissues was dramatically higher. CDCA4 expression was correlated with gender (Figure 5B) and age (Figure 5C) in osteosarcoma patients.
FIGURE 5
CDCA4 Expression Was Markedly Up-Regulated in Osteosarcoma Tissues and Cell Lines
To investigate CDCA4 functions in osteosarcoma, we measured CDCA4 expression in 12 paired normal and osteosarcoma tissues by qRT-PCR assays. The data indicated compared to normal tissue, CDCA4 expression level was largely raised in osteosarcoma tissues (Figure 6A). Next, we kept on evaluating CDCA4 expression in osteosarcoma cells (HOS, SW1353, and U2OS) and normal cell (hFOB1.19). The results showed that CDCA4 expression was greatly enhanced in osteosarcoma cells (Figure 6B).
FIGURE 6
Reduction of CDCA4 Could Inhibit Osteosarcoma Cell Proliferation, Migration, and Invasion
For clearly clarifying CDCA4 function in osteosarcoma occurrence and development, we transfected siRNA specifically targeting CDCA4 into SW1353 and U2OS cells, respectively. qRT-PCR data suggested that siRNA efficiently knocked down CDCA4 in SW1353 (Figure 7A) and U2OS (Figure 7B) cell. CCK 8 detection results revealed that reduced CDCA4 would suppress SW1353 and U2OS cell proliferation (Figures 7C,D). As shown in Figure 8, the results of Transwell assay showed that knocking out CDCA4 inhibited the invasion and migration of osteosarcoma cells. Taken together, our data indicated that reduction of CDCA4 could result in inhibition of osteosarcoma cell proliferation, migration, and invasion.
FIGURE 7
FIGURE 8
Discussion
Aerobic exercise refers to a dynamic, rhythmic exercise involving a large number of muscle groups and aerobic metabolism in the body. Aerobic exercise can improve bone health and restore hemostasis of bone tissue by restoring bone biomarkers including bone alkaline phosphatase and calcium (; ). Osteosarcoma is a malignant bone tumor consisting of mesenchymal cells that produce osteoid and immature bone. Successful treatment of osteosarcoma patients requires the close cooperation of an experienced multidisciplinary teams, including pediatric or internal oncologists, surgeons, pathologists, and radiologists (; ). Physical exercise has been identified as a low-cost, safe and effective way to treat chronic intractable pain (). Through the analysis of gene differential expression on the GSE74194 database, we obtained 547 aerobic exercise-related DEGs, 373 were up-regulated and 174 were down-regulated.
Many genes are reported to participate in osteosarcoma tumorigenesis (; ; ). Amid these genes, growth and differentiation factor 15 is one of representative gene. Its expression is increased in metastatic osteosarcoma tissues and has relation with the OS of osteosarcoma patients. Meanwhile, it is significantly related to the time of lung metastasis-free survival (MFS) (). showed that the metastasis inhibitor gene KISS-1 modulated apoptosis and autophagy processes of osteosarcoma. However, the molecular mechanism of CDCA4 in osteosarcoma has not been clarified.
CDCA4 encodes a protein that belongs to the E2F family of transcription factors and is widely expressed in bone marrow. It can regulate the transcriptional activity of target genes like p53, E2F, JUN in the cell cycle and proliferation (; ; ). CDCA4 functions importantly during many biological processes, such as proliferation and apoptosis (; ). Although the research on the structure and function of CDCA4 has been gradually carried out, the depth and breadth still need to be expanded. In this study, 90 key genes related to aerobic exercise were obtained through PPI network analysis, including CDCA4, LMNB2, BUB1, TPX2, PAD51AP1, KIF4A, MEUK, SPDL1, RAN, and POLD2, etc. DAVID method was executed to perform Gene ontology analysis for biological processes (BP). The data revealed that DEGs modulated mitotic cell cycle, cell division, mitotic nuclear division and sister chromatid segregation, nuclear division, microtubule cytoskeleton organization involved protein, microtubule-based process, spindle organization, G2/M transition of mitotic cell cycle. GO enrichment analysis indicated that CDCA4 was largely enriched in cell cycle (P < 0.05). According to the results of the comprehensive analysis, CDCA4 was selected for further research.
In order to explore the role of CDCA4 in osteosarcoma, based on the TCGA database, CDCA4 expression, prognostic value and clinicopathological features in osteosarcoma were analyzed. Compared with normal tissue, CDCA4 expression was significantly increased in SARC tissues. The high CDCA4 level was associated with poor prognosis in SARC patients. In addition, in patients with SARC, CDCA4 expression was related to gender and age. Studies have found that osteosarcoma has a bimodal age distribution, with the first peak in adolescence and the second peak in adulthood (). The first peak is in the age range of 10–14 years, which coincides with the sudden increase in puberty growth. It is suggested that the sudden increase of osteosarcoma in adolescence is closely related to the occurrence of osteosarcoma. The second peak of osteosarcoma occurred in adults over 65 years old. A second malignancy is more likely to be associated with Paget’s disease (). It has always been believed that the incidence of osteosarcoma in men is higher than in women. Interestingly, the expression level of CDCA4 is higher in female SARC patients, which may be related to the patients’ aerobic exercise. Taken together, these findings indicated that CDCA4 was a potential novel target for the treatment of SARC patients and a biomarker for prognosis.
Subsequently, qRT-PCR analysis showed that CDCA4 was highly expression in osteosarcoma tissues and cell lines. In vitro functional test data showed that CDCA4 was closely related to the regulation of osteosarcoma cell proliferation, migration and invasion. In summary, our findings indicate that CDCA4 may play a carcinogenic role in osteogenic sarcoma. Interestingly, the analysis of the GSE74194 database found that the expression of CDCA4 decreased after aerobic exercise. The major objective of the exercise-oncology research is to evaluate how aerobic exercise affect the incidence, progression, and metastasis of cancer and relevant biological mechanisms. A number of observational evidence showed that higher levels of exercise were negatively associated with the incidence of several types of cancer (; ; ; ). Also, there are data showing that exercise after cancer diagnosis may improve prognosis of early-stage cancers such as prostate and colorectal cancer (; ; ). The current hypothesis is that exercise regulates tumor progression by regulating host-tumor interactions (). Tumor progression is regulated by complex and multifaceted interactions between the host, tumor microenvironment and cancer cells which are subject to systemic and local growth factors, cytokines, hormones, and so on. Factors such as IL6,TNF, leptin, and insulin have already been reported to associate with higher recurrence and mortality (). Obviously, manipulating these factors through exercise can influence cancer progression. Therefore, in our study, we guess that aerobic exercise can decrease the expression of oncogene CDCA4 to impede cancer development, indicating that appropriate aerobic exercise might be helpful to the treatment and prognosis of patients with osteosarcoma. All in all, these data suggested that aerobic exercise could affect osteosarcoma by regulating CDCA4 expression which provided a whole new perspective for the study of osteosarcoma.
To sum up, comprehensive bioinformatics analysis provides a simple and flexible method. Through a comprehensive analysis of the GSE74194 database, we have identified key genes related to aerobic exercise. CDCA4 expression was lower in aerobic exercise group than in anaerobic exercise group. Based on the analysis of the TCGA-SARC database, the upregulation of CDCA4 expression was associated with poor prognosis in patients with SARC. We conducted a series of experiments in the study to explore the exact role of CDCA4 in osteosarcoma progression. Our data showed that CDCA4 was elevated in osteosarcoma tissues and cell lines and affected cell proliferation, migration, and invasion. All in all, our research may provide a new perspective for the study of osteogenic sarcoma, indicating aerobic exercise can help improve the treatment of patients with osteogenic sarcoma.
Statements
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.
Ethics statement
The studies involving human participants were reviewed and approved by the ethics committee of Minhang Hospital. The patients/participants provided their written informed consent to participate in this study.
Author contributions
SH, JZ, and XZ: conception and design. JQ, LY, and QX: development of methodology. SH, JZ, and JQ: analysis and interpretation of data. XZ, JQ, LY, and QX: writing, review, and revision of the manuscript. All authors contributed to the article and approved the submitted version.
Acknowledgments
It was greatly appreciated that the referees offered their precious comments and suggestions which benefited the improvement of our manuscript.
Conflict of interest
SH was employed by the company Shuangwu Information Technical Company Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Abbreviations
- BP
Biological Processes
- CDCA4
Cell Division Cycle-associated Protein 4
- DEGs
Differentially Expressed Genes
- GO
Gene Ontology
- GEO
Gene Expression Omnibus
- MFS
Metastasis-free Survival
- NSCLC
Non-small Cell Lung Cancer
- OS
Overall Survival
- PPI
Protein-protein Interaction Network
- qRT-PCR
Quantitative Reverse Transcription Polymerase Chain Reaction
- STRING
The Search Tool for the Retrieval of Interacting Genes
- SARC
Sarcoma
- TNBC
Triple Negative Breast Cancer
- TCGA
The Cancer Genome Atlas.
Footnotes
1.^https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi
2.^https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga
References
1
Al DahamshehZ.Al RashdanK.AladidA.JaradatR.Al BakheetM.BatainehZ. S. (2019). The impact of aerobic exercise on female bone health indicators.Med. Arch.7335–38.
2
AldermanC.SehlaouiA.XiaoZ.YangY. (2016). MicroRNA-15a inhibits the growth and invasiveness of malignant melanoma and directly targets on CDCA4 gene.Tumour Biol.3713941–13950. 10.1007/s13277-016-5271-z
3
AshcraftK. A.PeaceR. M.BetofA. S.DewhirstM. W.JonesL. W. (2016). Efficacy and mechanisms of aerobic exercise on cancer initiation, progression, and metastasis: a critical systematic review of In Vivo preclinical data.Cancer Res.764032–4050. 10.1158/0008-5472.can-16-0887
4
Ballard-BarbashR.FriedenreichC. M.CourneyaK. S.SiddiqiS. M.McTiernanA.AlfanoC. M. (2012). Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review.J. Natl. Cancer Inst.104815–840. 10.1093/jnci/djs207
5
BetofA. S.DewhirstM. W.JonesL. W. (2013). Effects and potential mechanisms of exercise training on cancer progression: a translational perspective.Brain Behav. Immun.30(Suppl. 0)S75–S87.
6
BiazzoA.De PaolisM. (2016). Multidisciplinary approach to osteosarcoma.Acta Orthop. Belg.82690–698.
7
BishopM. W.JanewayK. A.GorlickR. (2016). Future directions in the treatment of osteosarcoma.Curr. Opin. Pediatr.2826–33. 10.1097/mop.0000000000000298
8
CambienB.RezzonicoR.VitaleS.Rouzaire-DuboisB.DuboisJ. M.BarthelR.et al (2008). Silencing of hSlo potassium channels in human osteosarcoma cells promotes tumorigenesis.Int. J. Cancer123365–371. 10.1002/ijc.23511
9
CampbellK. L.McTiernanA.LiS. S.SorensenB. E.YasuiY.LampeJ. W.et al (2007). Effect of a 12-month exercise intervention on the apoptotic regulating proteins Bax and Bcl-2 in colon crypts: a randomized controlled trial.Cancer Epidemiol. Biomark. Prevent.161767–1774. 10.1158/1055-9965.epi-07-0291
10
ChenG.WangM.LiuX. (2019). GDF15 promotes osteosarcoma cell migration and invasion by regulating the TGFbeta signaling pathway.Mol. Med. Rep.204262–4270.
11
ChenY.WangS.GengB.YiZ. (2018). Pelargonidin induces antitumor effects in human osteosarcoma cells via autophagy induction, loss of mitochondrial membrane potential, G2/M cell cycle arrest and downregulation of PI3K/AKT signalling pathway.J. BUON23735–740.
12
DainoK.UgolinN.Altmeyer-MorelS.GuillyM. N.ChevillardS. (2009). Gene expression profiling of alpha-radiation-induced rat osteosarcomas: identification of dysregulated genes involved in radiation-induced tumorigenesis of bone.Int. J. Cancer125612–620. 10.1002/ijc.24392
13
Dieli-ConwrightC. M.CourneyaK. S.Demark-WahnefriedW.SamiN.LeeK.SweeneyF. C.et al (2018). Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial.Breast Cancer Res.20:124.
14
EsserK. A.HarpoleC. E.PrinsG. S.DiamondA. M. (2009). Physical activity reduces prostate carcinogenesis in a transgenic model.Prostate691372–1377. 10.1002/pros.20987
15
FriedenreichC. M.WoolcottC. G.McTiernanA.Ballard-BarbashR.BrantR. F.StanczykF. Z.et al (2010). Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women.J. Clin. Oncol.281458–1466. 10.1200/jco.2009.24.9557
16
GarciaM. B.NessK. K.SchadlerK. L. (2020). Exercise and physical activity in patients with osteosarcoma and survivors.Adv. Exp. Med. Biol.1257193–207. 10.1007/978-3-030-43032-0_16
17
GennariL.RendinaD.FalchettiA.MerlottiD. (2019). Paget’s disease of bone.Calcif. Tissue Int.104483–500.
18
GueritatJ.Lefeuvre-OrfilaL.VincentS.CretualA.RavanatJ. L.Gratas-DelamarcheA.et al (2014). Exercise training combined with antioxidant supplementation prevents the antiproliferative activity of their single treatment in prostate cancer through inhibition of redox adaptation.Free Rad. Biol. Med.7795–105. 10.1016/j.freeradbiomed.2014.09.009
19
HayashiR.GotoY.IkedaR.YokoyamaK. K.YoshidaK. (2006). CDCA4 is an E2F transcription factor family-induced nuclear factor that regulates E2F-dependent transcriptional activation and cell proliferation.J. Biol. Chem.28135633–35648. 10.1074/jbc.m603800200
20
JonesL. W.AlfanoC. M. (2013). Exercise-oncology research: past, present, and future.Acta Oncol.52195–215. 10.3109/0284186x.2012.742564
21
KagerL.TamamyanG.BielackS. (2017). Novel insights and therapeutic interventions for pediatric osteosarcoma.Future Oncol.13357–368. 10.2217/fon-2016-0261
22
LamoureuxF.TrichetV.ChipoyC.BlanchardF.GouinF.RediniF. (2007). Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.Expert Rev. Anticancer Ther.7169–181. 10.1586/14737140.7.2.169
23
MaeharaH.KanameT.YanagiK.HanzawaH.OwanI.KinjouT.et al (2007). Midkine as a novel target for antibody therapy in osteosarcoma.Biochem. Biophys. Res. Commun.358757–762. 10.1016/j.bbrc.2007.04.183
24
Messaggi-SartorM.MarcoE.Martínez-TéllezE.Rodriguez-FusterA.PalomaresC.ChiarellaS.et al (2019). Combined aerobic exercise and high-intensity respiratory muscle training in patients surgically treated for non-small cell lung cancer: a pilot randomized clinical trial.Eur. J. Phys. Rehabili. Med.55113–122.
25
NanX.WangJ.ChengH.YinZ.ShengJ.QiuB.et al (2020). Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.Cancer Lett.469195–206. 10.1016/j.canlet.2019.10.034
26
NelsonN. L. (2016). Breast cancer-related lymphedema and resistance exercise: a systematic review.J. Strength Cond. Res.302656–2665. 10.1519/jsc.0000000000001355
27
OttavianiG.JaffeN. (2009). The epidemiology of osteosarcoma.Cancer Treat. Res.1523–13. 10.1007/978-1-4419-0284-9_1
28
PangS.XuY.ChenJ.LiG.HuangJ.WuX. (2019). Knockdown of cell division cycle-associated protein 4 expression inhibits proliferation of triple negative breast cancer MDA-MB-231 cells in vitro and in vivo.Oncol. Lett.174393–4400.
29
PicciP. (2007). Osteosarcoma (osteogenic sarcoma).Orphanet J. Rare Dis.2:6.
30
SampsonV. B.YooS.KumarA.VetterN. S.KolbE. A. (2015). MicroRNAs and potential targets in osteosarcoma: review.Front. Pediatr.3:69. 10.3389/fped.2015.00069
31
SantosL.Elliott-SaleK. J.SaleC. (2017). Exercise and bone health across the lifespan.Biogerontology18931–946. 10.1007/s10522-017-9732-6
32
SchmidtM. E.WiskemannJ.ArmbrustP.SchneeweissA.UlrichC. M.SteindorfK. (2015). Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: a randomized controlled trial.Int. J. Cancer137471–480. 10.1002/ijc.29383
33
SenbaE.KamiK. (2017). A new aspect of chronic pain as a lifestyle-related disease.Neurobiol. Pain16–15. 10.1016/j.ynpai.2017.04.003
34
SerraM.HattingerC. M. (2017). The pharmacogenomics of osteosarcoma.Pharmacogenomics J.1711–20. 10.1038/tpj.2016.45
35
TaranS. J.TaranR.MalipatilN. B. (2017). Pediatric osteosarcoma: an updated review.Indian J. Med. Paediatr. Oncol.3833–43. 10.4103/0971-5851.203513
36
TateguM.NakagawaH.HayashiR.YoshidaK. (2008). Transcriptional co-factor CDCA4 participates in the regulation of JUN oncogene expression.Biochimie901515–1522. 10.1016/j.biochi.2008.05.014
37
Watanabe-FukunagaR.IidaS.ShimizuY.NagataS.FukunagaR. (2005). SEI family of nuclear factors regulates p53-dependent transcriptional activation.Genes Cells10851–860. 10.1111/j.1365-2443.2005.00881.x
38
XieL.YaoZ.ZhangY.LiD.HuF.LiaoY.et al (2018). Deep RNA sequencing reveals the dynamic regulation of miRNA, lncRNAs, and mRNAs in osteosarcoma tumorigenesis and pulmonary metastasis.Cell Death Dis.9:772.
39
XuM.WangZ.YuX. C.LinJ. H.HuY. C. (2020). Guideline for limb-salvage treatment of osteosarcoma.Orthop. surg.121021–1029. 10.1111/os.12702
40
XuY.WuX.LiF.HuangD.ZhuW. (2018). CDCA4, a downstream gene of the Nrf2 signaling pathway, regulates cell proliferation and apoptosis in the MCF-7/ADM human breast cancer cell line.Mol. Med. Rep.171507–1512.
41
YangD.LiuK.FanL.LiangW.XuT.JiangW.et al (2020). LncRNA RP11-361F15.2 promotes osteosarcoma tumorigenesis by inhibiting M2-Like polarization of tumor-associated macrophages of CPEB4.Cancer Lett.47333–49. 10.1016/j.canlet.2019.12.041
42
YinY.TangL.ShiL. (2017). The metastasis suppressor gene KISS-1 regulates osteosarcoma apoptosis and autophagy processes.Mol. Med. Rep.151286–1290. 10.3892/mmr.2017.6109
Summary
Keywords
CDCA4, osteosarcoma, aerobic exercise, comprehensive analysis, progression
Citation
Hao S, Zhu J, Zhang X, Qiu J, Xuan Q and Ye L (2021) Comprehensive Analysis of Aerobic Exercise-Related Genes Identifies CDCA4 That Promotes the Progression of Osteosarcoma. Front. Genet. 12:637755. doi: 10.3389/fgene.2021.637755
Received
04 December 2020
Accepted
08 January 2021
Published
03 February 2021
Volume
12 - 2021
Edited by
Tao Huang, Shanghai Institute of Nutrition and Health (CAS), China
Reviewed by
Yifei Cheng, Huashan Hospital, China; Zhang Yang, Independent Researcher, China
Updates
Copyright
© 2021 Hao, Zhu, Zhang, Qiu, Xuan and Ye.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Qin Xuan, 1917225004@qq.comLiping Ye, yeliping_1017@126.com; yeliping12138@126.com
†These authors have contributed equally to this work
This article was submitted to Cancer Genetics, a section of the journal Frontiers in Genetics
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.